Act-HIB Dosage/Direction for Use

Dosage: Before 6 months of age, 3 successive doses of 0.5 ml administered one or two months apart, followed by a booster injection (0.5 ml) one year after the third injection.
Between 6 and 12 months of age, 2 doses of 0.5 ml administered one month apart, followed by a booster injection (0.5 ml) at 18 months of age.
From 1 to 5 years of age, a single dose of 0.5 ml.
For contact cases: In the event of a contact with a case of invasive Haemophilus influenzae type b infection (family or childcare), vaccination should be implemented according to the schedule for the contact case's age.
The index case (the first case identified in an organisation or a community) must also be vaccinated.
If the patient forgets to use Act-HIB 10 micrograms/0.5 ml, powder and solvent for solution for injection in pre-filled syringe: If the patient forgets to take one dose of the vaccine, the doctor will decide when to administer this dose.
If the patient stops using Act-HIB 10 micrograms/0.5 ml, powder and solvent for solution for injection in pre-filled syringe: Not applicable.
If the patient/parent has any further questions on the use of this medicine, advise the patient/parent to ask the doctor or pharmacist.
Method of administration: This vaccine will be administered to the child by a healthcare professional preferably into a muscle or deep under the skin, into a thigh or into an arm.
This vaccine must never be administered into a blood vessel.
Additional information: Reconstitute the solution, either by injecting the content of the syringe of solvent into the vial of powder or by injecting the content of a syringe of combined diphtheria-tetanus-pertussis vaccine or a diphtheria-tetanus-pertussis-poliomyelitis vaccine.
Shake until the powder is completely dissolved.
The whitish, cloudy appearance of the suspension following reconstitution by a syringe of diphtheria-tetanus-pertussis or diphtheria-tetanus-pertussis-poliomyelitis vaccine is normal.
For syringes without attached needle, the separate needle must be fitted firmly to the syringe, rotating it by one quarter turn.
Do not inject by the intravascular route.
Administer via the intramuscular (preferably) or the deep-subcutaneous route: the recommended injection sites are the antero-lateral aspect of the thigh (middle third) for infants and toddlers and the deltoid region for older children.